Literature DB >> 9063530

Occasional diagnosis of synchronous renal cell carcinoma during staging of other primary tumors.

L Piccinini1, G Luppi, A Zoboli, P Torricelli.   

Abstract

Synchronous renal cell cancer (RCC) associated with primary neoplasms of other organs or tissues represents a rare diagnostic report during life. Recently, the widespread use of new diagnostic techniques (echography, computed tomography and magnetic resonance imaging) has permitted diagnosis of clinically silent RCC. We report 6 RCC cases occasionally diagnosed during initial staging of a primary cancer of other organs: 1 rhinopharyngeal carcinoma, 1 gastric cancer, 1 Waldenström's disease, 1 non-Hodgkin's lymphoma, 2 breast cancer, RCC was clinically silent in all patients. The diagnostic problems related to a report of a renal mass in patients with neoplastic disease at other sites and the consequent therapeutic implications are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 9063530     DOI: 10.1177/030089169608200516

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  Concurrent occurrence of three neoplasms including non-Hodgkin's lymphoma, renal cell carcinoma and leiomyoma in the same kidney.

Authors:  D Dinçol; A Arican; A Ensari; S Akyar; Y Bedük; A Cengiz
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Synchronous primary malignancies in breast and kidney: a rare case report.

Authors:  U A Kurlekar; A S Rayate
Journal:  Indian J Surg       Date:  2014-01-11       Impact factor: 0.656

3.  Breast Cancer with Synchronous Renal Cell Carcinoma: A Rare Presentation.

Authors:  Ravi Arjunan; Durgesh Kumar; K V Veerendra Kumar; C S Premlatha
Journal:  J Clin Diagn Res       Date:  2016-10-01

4.  Synchronous quadruple multiple primary cancers of the tongue, bilateral breasts, and kidney in a female patient with a disease-free survival time of more than 5 years: a case report.

Authors:  Tessho Maruyama; Toshiyuki Nakasone; Nobuyuki Maruyama; Akira Matayoshi; Akira Arasaki
Journal:  World J Surg Oncol       Date:  2015-08-28       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.